CClinicalTrials.gg
CompletedNCT05214118BETTERUpdated Jul 18, 2025Results posted

Bringing Education Through Technology, Empathic Listening, and Research

An interventional study of technology-based program in Pregnancy Related, sponsored by Virginia Commonwealth University. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-18.

Sponsored by Virginia Commonwealth University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of this study is to test a new educational technology-based program and brochure as a supplement to prenatal education from providers. The program provides education about common challenges that pregnant and parenting women receiving medication for Opioid Use Disorder (OUD) often face. Specifically, it addresses the transition from pregnancy to postpartum, possible neonatal abstinence syndrome (NAS) or neonatal withdrawal syndrome (NOWS), and interactions with child welfare.

02

Conditions studied

  • Pregnancy Related
03

In context

Lead sponsor

Virginia Commonwealth University is the lead sponsor of 641 studies on the registry; 82 are open to participants now.

Of its 88 completed or terminated interventional studies of FDA-regulated products, 62 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  1. Female
  2. ≥18 years of age
  3. Meet criteria for Opioid Use Disorder
  4. Currently receiving MOUD pharmacotherapy (including buprenorphine, buprenorphine/naloxone, or methadone)
  5. Pregnant (\<34 weeks EGA)
  6. Initial in-person visit at OB MOTIVATE clinic for the current pregnancy ≤10 weeks ago

Exclusion criteria

Exclusion Criteria:

  1. Considering/planning adoption
  2. Present with a serious cognitive/psychiatric impairment
  3. Existing language barriers making true informed consent impossible
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
29 participants (actual)

Study arms

  • No intervention
    Brochure
  • Experimental
    Technology-based program

    Behavioral: technology-based program

Interventions

  • Behavioraltechnology-based program

    Participants will be asked to complete three 25-minute modules covering the transition from pregnancy to postpartum, possible neonatal abstinence syndrome (NAS) or neonatal withdrawal syndrome (NOWS), and interactions with child welfare.

06

What researchers measure

Primary outcomes

  1. Feasibility of the Intervention

    Participants will complete a survey about the feasibility of the intervention consisting of 4 items rated on a 0 to 6 scale. Scores will be summed to yield a final feasibility score ranging from 0 to 24. Higher scores indicate higher feasibility.

    Time frame: Within 2 weeks of completing the intervention

  2. Acceptability of the Intervention

    Participants will complete a survey about the acceptability of the intervention consisting of 10 items rated on a 1 to 5 scale. Higher scores indicated higher acceptability.

    Time frame: Within 2 weeks of completing the intervention

Secondary outcomes

  1. Change in Perceived Competence

    Participants will complete a survey assessing their feelings of competence related to the information covered by the intervention. The items will be rated on a 1 to 7 scale. Higher scores indicated higher perceived competence. An increase in perceived competence suggests a greater sense of confidence, mastery, and belief in one's ability to achieve goals within that area. This can be linked to positive outcomes like improved performance, motivation, and goal attainment. A decrease in perceived competence indicates a diminished sense of self-efficacy and belief in one's abilities, potentially leading to reduced motivation, avoidance of challenges, and lower engagement.

    Time frame: Baseline to within 2 weeks of completing the intervention, up to 5 weeks

  2. Change in Parental Competence

    Participants will complete a survey assessing their feelings of competence related to the parenting. The items will be rated on a 1 to 6 scale. An increase in perceived competence suggests a greater sense of confidence, mastery, and belief in one's ability to achieve goals within that area. This can be linked to positive outcomes like improved performance, motivation, and goal attainment. A decrease in perceived competence indicates a diminished sense of self-efficacy and belief in one's abilities, potentially leading to reduced motivation, avoidance of challenges, and lower engagement.

    Time frame: Baseline to within 2 weeks of completing the intervention, up to 5 weeks

07

Results

Posted Jul 18, 2025

Participant flow

Participant flow — Overall Study
MilestoneBrochureTechnology-based Program
Started1316
Completed1113
Not completed23
Withdrew: Lost to follow-up02
Withdrew: Delivered late preterm 34 wks gestation11
Withdrew: Moved10

Outcome measures

PrimaryFeasibility of the Intervention

Participants will complete a survey about the feasibility of the intervention consisting of 4 items rated on a 0 to 6 scale. Scores will be summed to yield a final feasibility score ranging from 0 to 24. Higher scores indicate higher feasibility.

Time frame:
Within 2 weeks of completing the intervention
Reported as:
Mean · score on a scale
Feasibility of the Intervention
score on a scaleBrochureTechnology-based Program
Feasibility of the Intervention21.5 ± 2.321.2 ± 2.9
PrimaryAcceptability of the Intervention

Participants will complete a survey about the acceptability of the intervention consisting of 10 items rated on a 1 to 5 scale. Higher scores indicated higher acceptability.

Time frame:
Within 2 weeks of completing the intervention
Reported as:
Mean · score on a scale
Acceptability of the Intervention
score on a scaleBrochureTechnology-based Program
Acceptability of the Intervention47.6 ± 5.548.3 ± 7.6
SecondaryChange in Perceived Competence

Participants will complete a survey assessing their feelings of competence related to the information covered by the intervention. The items will be rated on a 1 to 7 scale. Higher scores indicated higher perceived competence. An increase in perceived competence suggests a greater sense of confidence, mastery, and belief in one's ability to achieve goals within that area. This can be linked to positive outcomes like improved performance, motivation, and goal attainment. A decrease in perceived competence indicates a diminished sense of self-efficacy and belief in one's abilities, potentially leading to reduced motivation, avoidance of challenges, and lower engagement.

Time frame:
Baseline to within 2 weeks of completing the intervention, up to 5 weeks
Reported as:
Mean · mean score on a scale
Change in Perceived Competence
mean score on a scaleBrochureTechnology-based Program
Change in Perceived Competence.75 ± 9.7.3 ± 8.5
SecondaryChange in Parental Competence

Participants will complete a survey assessing their feelings of competence related to the parenting. The items will be rated on a 1 to 6 scale. An increase in perceived competence suggests a greater sense of confidence, mastery, and belief in one's ability to achieve goals within that area. This can be linked to positive outcomes like improved performance, motivation, and goal attainment. A decrease in perceived competence indicates a diminished sense of self-efficacy and belief in one's abilities, potentially leading to reduced motivation, avoidance of challenges, and lower engagement.

Time frame:
Baseline to within 2 weeks of completing the intervention, up to 5 weeks
Reported as:
Mean · mean score on a scale
Change in Parental Competence
mean score on a scaleBrochureTechnology-based Program
Change in Parental Competence3.3 ± 9-1.5 ± 11.5

Adverse events

Collected over February 2022-October 2023 overall for the study. During the duration of study involvement individually for each subject which is Baseline to within 2 weeks of completing the intervention, up to 5 weeks.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Brochure0/13 (0%)1/13 (7.7%)0/13 (0%)
Technology-based Program0/16 (0%)0/16 (0%)0/16 (0%)
Most frequent serious events
Most frequent serious events
EventBrochureTechnology-based Program
Cardiac disordersCardiac disorders1/130/16

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)BrochureTechnology-based ProgramTotal
<=18 years000
Between 18 and 65 years131629
>=65 years000
Age, Continuous
Age, Continuous(years)BrochureTechnology-based ProgramTotal
Mean30.3 ± 5.329.7 ± 3.630 ± 4.45
Sex: Female, Male
Sex: Female, Male(Participants)BrochureTechnology-based ProgramTotal
Female131629
Male000
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)BrochureTechnology-based ProgramTotal
Hispanic or Latino101
Not Hispanic or Latino121628
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)BrochureTechnology-based ProgramTotal
American Indian or Alaska Native011
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American369
White10919
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)BrochureTechnology-based ProgramTotal
United States131629
08

Study locations

1 site
  • Virginia Commonwealth University
    Richmond, Virginia 23298, United States
09

References and documents

Publications

  • Eglovitch M, Martin S, Thumma L, Svikis DS, Tyson K, Pearson K, Martin CE, Parlier-Ahmad AB. Project BETTER: Outcomes at the pregnancy-to-postpartum transition from a pilot clinical trial of a technology-delivered intervention for birthing people receiving medication for opioid use disorder. Fam Syst Health. 2025 Dec;43(4):758-763. doi: 10.1037/fsh0001030. PubMed 42008128 ↗

Study documents

  • Protocol and statistical analysis plan · Dec 21, 2021
  • Informed consent form · Nov 7, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05214118
Lead sponsor
Virginia Commonwealth University
Responsible party
Sponsor
First posted
Jan 28, 2022
Start date
Feb 2, 2022
Primary completion
Jan 22, 2024
Completion
Jan 22, 2024
Results posted
Jul 18, 2025
Last update
Jul 18, 2025

Study contacts

Caitlin E Martin, MD, MPH
principal investigator · Virginia Commonwealth University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion